Shares of Pfizer Inc. PFE, +0.71% gained 0.2% in premarket trading on Wednesday after the company said the experimental ulcerative colitis drug it bought through the recent Arena Pharmaceuticals deal ...
Shares of Pfizer Inc. PFE, +0.71% gained 0.2% in premarket trading on Wednesday after the company said the experimental ulcerative colitis drug it bought through the recent Arena Pharmaceuticals deal ...